Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors

Mol Divers. 2022 Aug;26(4):1995-2009. doi: 10.1007/s11030-021-10310-7. Epub 2021 Sep 13.

Abstract

A novel series of phenoxymethybenzoimidazole derivatives (9a-n) were rationally designed, synthesized, and evaluated for their α-glycosidase inhibitory activity. All tested compounds displayed promising α-glycosidase inhibitory potential with IC50 values in the range of 6.31 to 49.89 μM compared to standard drug acarbose (IC50 = 750.0 ± 10.0 μM). Enzyme kinetic studies on 9c, 9g, and 9m as the most potent compounds revealed that these compounds were uncompetitive inhibitors into α-glycosidase. Docking studies confirmed the important role of benzoimidazole and triazole rings of the synthesized compounds to fit properly into the α-glycosidase active site. This study showed that this scaffold can be considered as a highly potent α-glycosidase inhibitor.

Keywords: Benzimidazole; Enzyme inhibition; Synthesis; Triazole-acetamide; α-Glycosidase.

MeSH terms

  • Acetamides
  • Glycoside Hydrolase Inhibitors* / chemistry
  • Kinetics
  • Molecular Docking Simulation
  • Molecular Structure
  • Structure-Activity Relationship
  • Thiazoles / chemistry
  • Triazoles / chemistry
  • alpha-Glucosidases* / chemistry

Substances

  • Acetamides
  • Glycoside Hydrolase Inhibitors
  • Thiazoles
  • Triazoles
  • alpha-Glucosidases